Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | CFO & COO | October 01, 2026 | October 05, 2026 |
| VERACYTE, INC.VCYT · Entity 2018 | COO / CFO | March 02, 2021 | March 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 208,686 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Tax withholding · Disposed 3,018 · Balance 208,686 F1: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
VERACYTE, INC.
Report date March 02, 2021 · Filed March 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 116,858 |
Reported balance
After 2021-03-02 transaction · row 1
1 source rowRow 1 · 2021-03-02 · Tax withholding · Disposed 5,783 · Balance 116,858 F1: The reporting person is reporting the withholding of 284, 220, 3,519, 440 and 1,320 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 644, 500, 8,000, 1,000 and 3,000 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019, February 28, 2019, July 1, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of 284, 220, 3,519, 440 and 1,320 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 644, 500, 8,000, 1,000 and 3,000 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019, February 28, 2019, July 1, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 05, 2019 Filed Dec 9, 2019 21:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 11,942 | $7.47 | $89,206.74 |
DisclosureSEC source: 0001384101-19-000158 · wf-form4_157592591191238.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:20 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 340 | $27.19 | $9,244.60 |
DisclosureSEC source: 0001384101-19-000150 · wf-form4_157549441517000.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,703 F1 · shares: The reporting person is reporting the withholding of 340 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 644 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 21:28 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 18,757 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001384101-19-000140 · wf-form4_157489009934158.xml · derivative · entry 3 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,250 Underlying: Common Stock · 18,757 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 21:28 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 18,757 | $28.01 | $525,475.48 |
DisclosureSEC source: 0001384101-19-000140 · wf-form4_157489009934158.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,043 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.05. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 21:28 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 18,757 | $5.98 | $112,166.86 |
DisclosureSEC source: 0001384101-19-000140 · wf-form4_157489009934158.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 22:39 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 1,243 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001384101-19-000133 · wf-form4_157195661921684.xml · derivative · entry 3 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,007 Underlying: Common Stock · 1,243 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 22:39 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,243 | $28.00 | $34,804.00 |
DisclosureSEC source: 0001384101-19-000133 · wf-form4_157195661921684.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,043 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 22:39 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 1,243 | $5.98 | $7,433.14 |
DisclosureSEC source: 0001384101-19-000133 · wf-form4_157195661921684.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 20:06 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 22,365 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001384101-19-000126 · wf-form4_156900999279669.xml · derivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,635 Underlying: Common Stock · 22,365 shares Expires 2026-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option began to vest on December 6, 2017 and vests at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 20:06 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 22,365 | $7.47 | $167,066.55 |
DisclosureSEC source: 0001384101-19-000126 · wf-form4_156900999279669.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 21:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 340 | $25.09 | $8,530.60 |
DisclosureSEC source: 0001384101-19-000114 · wf-form4_156771820176780.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,678 F1 · shares: The reporting person is reporting the withholding of 340 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 644 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. F2 · balance_after: Includes 807 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on July 31, 2019. Read SEC document |
| July 01, 2019 Filed Jul 1, 2019 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000094 · wf-form4_156201539064647.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,211 F1 · shares: Restricted stock units awarded on July 1, 2019 vest 25% on July 1, 2020 and 1/16 on each quarterly vesting date thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:26 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 339 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000062 · wf-form4_155976638468536.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,211 F1 · shares: The reporting person is reporting the withholding of 339 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 643 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| March 02, 2019 Filed Mar 5, 2019 00:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000028 · wf-form4_155174484228465.xml · nonDerivative · entry 3 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,550 F4 · shares: The reporting person is reporting the withholding of 1,053 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,575 Restricted Stock Units granted on March 2, 2018. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4. F5 · balance_after: Includes 2,244 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on July 31, 2018 and 2,245 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on January 31, 2019. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 00:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $20.21 | $0.00 |
DisclosureSEC source: 0001384101-19-000028 · wf-form4_155174484228465.xml · derivative · entry 4 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-02-27 F6 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 00:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000028 · wf-form4_155174484228465.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,603 F3 · shares: Restricted stock units awarded on February 28, 2019 vest 25% on February 28, 2021 and 75% on February 28, 2022 subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 00:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000028 · wf-form4_155174484228465.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,603 F1 · shares: Restricted stock units awarded on February 28, 2019 vest 25% on March 2, 2020 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. F2 · balance_after: Includes 2,244 shares acquired under the Issuer's employee stock purchase plan ("ESPP") on July 31, 2018 and 2,245 shares acquired under the ESPP on January 1, 2019. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 00:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 77,250 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001384101-18-000016 · wf-form4_152029789111370.xml · derivative · entry 2 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,250 Underlying: Common Stock · 77,250 shares Expires 2028-03-02 F3 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous employment thereafter. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 00:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 10,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-18-000016 · wf-form4_152029789111370.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,114 F1 · shares: Restricted stock units (RSUs) awarded on March 2, 2018 vest 25% on March 2, 2019, and the remaining vest at a rate of 3/48 on each quarterly anniversary thereafter subject to continuing employment of the Reporting Person on each vesting date. F2 · balance_after: Includes 2,209 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on January 31, 2018. Read SEC document |
| December 06, 2017 Filed Dec 7, 2017 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 9,395 | $6.29 | $59,094.55 |
DisclosureSEC source: 0001384101-17-000072 · wf-form4_151268085963146.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,605 F1 · shares: The reporting person is reporting the withholding of 9,395 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 25,000 restricted stock units awarded on December 6, 2016. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 22:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001384101-17-000019 · wf-form4_148883817884046.xml · derivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-03-03 F1 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 22:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001384101-16-000006 · wf-form4_148123615262033.xml · derivative · entry 2 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2026-12-05 F2 · derivative.exercise_date: Beginning on December 6, 2017, 1/36 of the of shares vest each month for the following 36 months. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 22:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-16-000006 · wf-form4_148123615262033.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · shares: Restricted stock units awarded on December 6, 2016, which vest on December 6, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.